American Financial Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXO
VP
VC
LGM
RG
American Financial Group's ALXO Position: Q4 2021 in Review
American Financial Group sold out of ALX Oncology (ALXO) in Q4 2021, closing a stake of 5,613 shares — an estimated $415K sold.
American Financial Group first reported a position in ALXO in Q2 2021 and held it in 2 quarters. The position peaked at $415K in Q3 2021. 108 funds tracked by Wall St. Rank hold ALXO as of Q4 2021.
- American Financial Group reported no remaining ALX Oncology position as of Q4 2021 after selling out during the quarter.
- American Financial Group sold 5,613 ALX Oncology shares in Q4 2021, an estimated $415K.
- American Financial Group first reported a position in ALX Oncology in Q2 2021 and held it in 2 quarters.
- American Financial Group's ALX Oncology position peaked at $415K in Q3 2021.
- 108 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2021.
Based on American Financial Group's 13F filing for Q4 2021, filed 10 Feb 2022.